Finder may earn compensation from partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Verastem stock | $2.55

Learn how to easily invest in Verastem stock.

Verastem Inc is a biotechnology business based in the US. Verastem shares (VSTM) are listed on the NASDAQ and all prices are listed in US Dollars. Verastem employs 48 staff and has a trailing 12-month revenue of around 0.00.

How to buy shares in Verastem

  1. Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – VSTM – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Verastem stock price (NASDAQ: VSTM)

Use our graph to track the performance of VSTM stocks over time.

Verastem shares at a glance

Information last updated 2021-10-24.
Latest market close$2.55
52-week range$1.14 - $4.93
50-day moving average $2.81
200-day moving average $3.22
Wall St. target price$6.25
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-0.23

Buy Verastem shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Asset types Option trade fee Annual fee Signup bonus
Stocks, Options, ETFs, Cryptocurrency
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
J.P. Morgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$0 + $0.65/contract
Vanguard Personal Advisor
Stocks, Options, Mutual funds, ETFs
$20 per year
Financial advice powered by relationships, not commissions.
Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency
$0 + $0.50/contract
$0 per month
Deposit qualifying assets of $5,000+
A platform built for all kinds of traders and all styles of trading
Sofi Invest
Stocks, ETFs, Cryptocurrency
Get one free stock worth up to $1,000
Open an account
A free way to invest in stocks, ETFs and crypto.
$0 per year
Get a free stock valued up to $350
Open your Futu brokerage account via Moomoo
Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Verastem stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Verastem price performance over time

Historical closes compared with the close of $2.55 from 2021-10-22

1 week (2021-10-15) -7.61%
1 month (2021-09-24) -19.56%
3 months (2021-07-23) -22.96%
6 months (2021-04-23) -8.93%
1 year (2020-10-23) 109.02%
2 years (2019-10-23) 88.89%
3 years (2018-10-23) 5.6
5 years (2016-10-21) 82.14%

Verastem financials

Revenue TTM $9.8 million
Gross profit TTM $-14,436,000
Return on assets TTM -38.73%
Return on equity TTM -38.17%
Profit margin 0%
Book value $0.51
Market capitalisation $460.9 million

TTM: trailing 12 months

Shorting Verastem shares

There are currently 8.5 million Verastem shares held short by investors – that's known as Verastem's "short interest". This figure is 49.3% up from 5.7 million last month.

There are a few different ways that this level of interest in shorting Verastem shares can be evaluated.

Verastem's "short interest ratio" (SIR)

Verastem's "short interest ratio" (SIR) is the quantity of Verastem shares currently shorted divided by the average quantity of Verastem shares traded daily (recently around 3.9 million). Verastem's SIR currently stands at 2.2. In other words for every 100,000 Verastem shares traded daily on the market, roughly 2200 shares are currently held short.

However Verastem's short interest can also be evaluated against the total number of Verastem shares, or, against the total number of tradable Verastem shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Verastem's short interest could be expressed as 0.05% of the outstanding shares (for every 100,000 Verastem shares in existence, roughly 50 shares are currently held short) or 0.0474% of the tradable shares (for every 100,000 tradable Verastem shares, roughly 47 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Verastem.

Find out more about how you can short Verastem stock.

Verastem share dividends

We're not expecting Verastem to pay a dividend over the next 12 months.

Verastem share price volatility

Over the last 12 months, Verastem's shares have ranged in value from as little as $1.14 up to $4.93. A popular way to gauge a stock's volatility is its "beta".

VSTM.US volatility(beta: 0.78)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Verastem's is 0.7825. This would suggest that Verastem's shares are less volatile than average (for this exchange).

Verastem overview

Verastem, Inc. , a development-stage biopharmaceutical company, focusing on developing and commercializing medicines to enhance the life of cancer patients. Its product in development include VS-6766, a dual rapidly accelerated fibrosarcoma (RAF)/mitogen-activated protein kinase (MEK) inhibitor that blocks MEK kinase activity and the ability of RAF to phosphorylate MEK. The company also engages in developing RAMP 201, an adaptive two-part multicenter open label trial to evaluate the efficacy and safety of VS-6766 and in combination with defactinib, an oral small molecule inhibitor of focal adhesion kinase (FAK) in patients with recurrent low grade serous ovarian cancer; and RAMP 202, which is in Phase 2 trial to evaluate the safety of VS-6766 in combination with defactinib in patients with KRAS mutant non-small cell lung cancer following treatment with a platinum-based regimen and immune checkpoint inhibitor. Verastem, Inc. has license agreements with Chugai Pharmaceutical Co. , Ltd.

Frequently asked questions

What percentage of Verastem is owned by insiders or institutions?
Currently 0.683% of Verastem shares are held by insiders and 65.285% by institutions.
How many people work for Verastem?
Latest data suggests 48 work at Verastem.
When does the fiscal year end for Verastem?
Verastem's fiscal year ends in December.
Where is Verastem based?
Verastem's address is: 117 Kendrick Street, Needham, MA, United States, 02494
What is Verastem's ISIN number?
Verastem's international securities identification number is: US92337C1045
What is Verastem's CUSIP number?
Verastem's Committee on Uniform Securities Identification Procedures number is: 92337C104

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site